MLchartDataset catalogue

Manganese-based MRI contrast agent RVP-001

Term · Oncology and biomedicine · MLC-T-ONC-015000

A contrast agent formulation based on the paramagnetic ion Mn2+, stabilized by the chelator PyC3A, that can potentially be used as a contrast enhancer during magnetic resonance imaging (MRI). Upon administration, manganese-based contrast agent RVP-001 may enhance the visualization of blood vessels, organs and tumors upon MRI.

Table 1. Record
IdentifierMLC-T-ONC-015000
FieldOncology and biomedicine
SynonymsMn-PyC3A; MnPyC3A
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015000",
  "term": "Manganese-based MRI contrast agent RVP-001",
  "field": "Oncology and biomedicine",
  "definition": "A contrast agent formulation based on the paramagnetic ion Mn2+, stabilized by the chelator PyC3A, that can potentially be used as a contrast enhancer during magnetic resonance imaging (MRI). Upon administration, manganese-based contrast agent RVP-001 may enhance the visualization of blood vessels, organs and tumors upon MRI.",
  "synonyms": [
    "Mn-PyC3A",
    "MnPyC3A"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/manganese-based-mri-contrast-agent-rvp-001/"
}

Record 10,610 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.